Health · Medical Research · 1 hr ago
Study Finds Heart Hormone May Promote Dangerous Blood Clots
Researchers at Texas A&M found that BNP can help trigger blood clots in experiments.
BNP is a hormone released when the heart is under strain, and doctors measure it as a sign of heart failure and other heart problems.
The team found BNP acts on a receptor called NPRA on platelets, the blood components that normally gather to stop bleeding.
This signal made platelets more likely to stick together and helped clots grow in experiments involving blood-vessel injury and pulmonary embolism.
Blocking NPRA or removing its gene prevented abnormal clotting in those experiments.
In blood samples from patients with heart rhythm disorders, higher BNP levels were linked to greater platelet activity, but this does not prove BNP causes clots in people.
The findings could guide more targeted clot prevention, though the research does not say when or whether a treatment will follow.
Researchers found that elevated B-type natriuretic peptide (BNP), a hormone used as a sign of heart strain, can activate platelets and speed clot formation in experiments.
The study identified the platelet receptor NPRA as the route through which BNP triggers this activity.
Blocking NPRA or removing its gene prevented BNP from activating platelets and protected against abnormal clotting in experiments.
Blood samples from patients with heart rhythm disorders showed an association between higher BNP levels and greater platelet activity.
The researchers said the findings could point to a targeted way to prevent dangerous clots, but the patient results do not establish that BNP causes clotting in people.
- Who
- Researchers at Texas A&M University’s Irma Lerma Rangel College of Pharmacy, led by Dr. Zhenyu Li.
- What
- The study found that BNP can activate platelets and accelerate clot formation in experiments.
- When
- The study was published on November 20, 2026.
- Where
- Texas A&M Health; the research also used experiments involving blood-vessel injury and pulmonary embolism.
- Why
- The researchers investigated whether BNP, commonly used as a warning sign of heart problems, could also contribute to clotting.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Hormone
- B-type natriuretic peptide (BNP)
- Platelet receptor
- Natriuretic peptide receptor-A (NPRA)
- Signaling molecule
- Cyclic guanosine monophosphate (cGMP)
- Research institution
- Texas A&M University Irma Lerma Rangel College of Pharmacy
- Journal
- Blood
What people are saying
We thought that BNP might not only act as a passive marker but actively contributes to the pathogenesis and progression of cardiovascular disease.
It was previously unknown whether platelets even expressed this receptor,
We are the first team to investigate whether BNP directly activates platelets through the NPRA receptor.
Knocking out the NPRA gene protected against these complications, proving the clotting process is mediated by the NPRA receptor,